The pathway analysis demonstrated that, again, B cell receptor signaling, PI3K signaling and NFkB signaling were among the most strongly affected pathways in 13q-H patients (Figure 3), highlighting the importance of miRNA regulation in CLL. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.